Progress in Alzheimer’s Disease research, but a cure will take time. Delaying it and disseminating that research may buy scientists the time they need

Biological engineering project featuring GSK seeks to use food by-products to create antimicrobials.

We ask about the story behind Nanoform and what nanotechnology could do for drug formulation.

The pharmaceutical trade show CPhI North America 2024 starts in Philadelphia. Here’s The Medicine Maker’s guide to day three.

Phesi CEO Gen Li discusses the impacts of the conflict between Russia and Ukraine on clinical trials

How – and why – we are tackling opioid use disorder with a monoclonal antibody

CPhI North America continues. Here’s our must-see highlights of day 2 at the show.

CPhI North America begins today. Here’s our guide to day 1 at the show.

Preparing for the EU’s new HTA regulation and Joint Clinical Assessment process

Veeva’s Richard Young looks back on breakthroughs in clinical trial technology and why the industry must continue to make trials more patient centric.